Ost-müük Astria Therapeutics, Inc. - ATXS CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | - | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | N/A |
| Avatud* | N/A |
| Aastane muutus* | N/A |
| Päeva ulatus* | N/A |
| 52 nädala ulatus | 2.36-16.28 |
| Keskmine maht (10 päeva) | 324.43K |
| Keskmine maht (3 kuud) | 4.92M |
| Turukapitalisatsioon | 308.29M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 27.50M |
| Tulu | N/A |
| EPS | -3.64 |
| Dividendid (% kasumist) | N/A |
| Beeta | 0.92 |
| Järgmine tuluaruande kuupäev | Mar 22, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|
Astria Therapeutics, Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 | 0.5 |
| Kogu tegevuskulu | 194.976 | 37.435 | 27.088 | 26.371 | 27.594 |
| Müük/Üldine/admin kulud, kokku | 14.807 | 11.845 | 8.771 | 9.329 | 8.912 |
| Uuringud ja arendus | 180.169 | 25.59 | 18.317 | 17.042 | 18.682 |
| Tulud majandustegevusest | -194.976 | -37.435 | -27.088 | -26.371 | -27.094 |
| Intressitulud (kulu), muud tulud, neto | 0.122 | 0.236 | 0.845 | 0.325 | -0.302 |
| Muud, neto | -0.058 | -0.101 | -0.05 | 0.176 | 0.032 |
| Netotulu enne makse | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
| Netotulu pärast makse | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
| Netotulu enne erikulusid | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
| Netotulu | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
| Arvestatav tulu, v a erikulud | -219.349 | -37.3 | -26.293 | -25.87 | -27.364 |
| Arvestatav tulu, koos erikuludega | -219.349 | -37.3 | -26.293 | -25.87 | -27.364 |
| Jaotamisele kuuluv netotulu | -219.349 | -37.3 | -26.293 | -25.87 | -27.364 |
| Keskmine jaotamisele kuuluv aktsia kohta | 8.92517 | 3.05864 | 1.86655 | 0.84249 | 0.36137 |
| Jaotatav EPS, v a erakorralised kulud | -24.5764 | -12.195 | -14.0864 | -30.7067 | -75.7237 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Jaotamisele kuuluv normaal-EPS | -24.5764 | -12.195 | -14.0864 | -30.7067 | -75.7237 |
| Tulu | 0 | 0.5 | |||
| Erakorralised kulud kokku | 0 | ||||
| Total Adjustments to Net Income | -24.437 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 | 0 |
| Kogu tegevuskulu | 15.378 | 9.508 | 7.898 | 7.486 | 170.085 |
| Müük/Üldine/admin kulud, kokku | 5.02 | 3.815 | 4.11 | 4.008 | 2.88 |
| Uuringud ja arendus | 10.358 | 5.693 | 3.788 | 3.478 | 167.205 |
| Tulud majandustegevusest | -15.378 | -9.508 | -7.898 | -7.486 | -170.085 |
| Muud, neto | -0.001 | -0.016 | -0.008 | -0.02 | 0.001 |
| Netotulu enne makse | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
| Netotulu pärast makse | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
| Netotulu enne erikulusid | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
| Netotulu | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
| Arvestatav tulu, v a erikulud | -15.323 | -9.491 | -7.871 | -31.903 | -170.084 |
| Arvestatav tulu, koos erikuludega | -15.323 | -9.491 | -7.871 | -31.903 | -170.084 |
| Jaotamisele kuuluv netotulu | -15.323 | -9.491 | -7.871 | -31.903 | -170.084 |
| Keskmine jaotamisele kuuluv aktsia kohta | 13.017 | 13.0598 | 12.8308 | 5.98022 | 3.7301 |
| Jaotatav EPS, v a erakorralised kulud | -1.17716 | -0.72673 | -0.61345 | -5.33476 | -45.5977 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -1.17716 | -0.72673 | -0.61345 | -5.33476 | -45.5977 |
| Intressitulud (kulu), muud tulud, neto | 0.056 | 0.033 | 0.035 | 0.04 | |
| Total Adjustments to Net Income | 0 | 0 | -24.437 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 127.075 | 46.325 | 38.958 | 38.915 | 17.463 |
| Raha ja lühiajalised investeeringud | 125.508 | 44.93 | 36.244 | 37.57 | 16.369 |
| Raha ja ekvivalendid | 1.853 | 22.999 | 5.432 | 5.956 | 16.369 |
| Lühiajalised investeeringud | 39 | 20 | 26.345 | 22.276 | 0 |
| Prepaid Expenses | 1.446 | 1.274 | 2.237 | 1.345 | 1.094 |
| Total Assets | 127.514 | 47.456 | 41.78 | 39.169 | 17.897 |
| Property/Plant/Equipment, Total - Net | 0.394 | 0.966 | 2.349 | 0.056 | 0.321 |
| Property/Plant/Equipment, Total - Gross | 0.377 | ||||
| Accumulated Depreciation, Total | -0.321 | ||||
| Other Long Term Assets, Total | 0.045 | 0.165 | 0.473 | 0.198 | 0.113 |
| Total Current Liabilities | 5.203 | 6.39 | 5.032 | 4.171 | 6.016 |
| Accounts Payable | 1.557 | 1.544 | 1.197 | 1.408 | 0.773 |
| Accrued Expenses | 3.646 | 4.846 | 3.835 | 2.763 | 2.432 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 2.479 | |||
| Total Liabilities | 5.203 | 6.787 | 6.06 | 4.227 | 6.105 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | 0 | ||||
| Other Liabilities, Total | 0 | 0.397 | 1.028 | 0.056 | 0.089 |
| Total Equity | 122.311 | 40.669 | 35.72 | 34.942 | 11.792 |
| Common Stock | 0.013 | 0.02 | 0.012 | 0.007 | 0.024 |
| Additional Paid-In Capital | 481.709 | 301.546 | 259.305 | 232.243 | 183.202 |
| Retained Earnings (Accumulated Deficit) | -455.809 | -260.897 | -223.597 | -197.304 | -171.434 |
| Other Equity, Total | 0 | 0 | -0.004 | 0 | |
| Total Liabilities & Shareholders’ Equity | 127.514 | 47.456 | 41.78 | 39.169 | 17.897 |
| Total Common Shares Outstanding | 13.017 | 3.34746 | 2.07227 | 0.11903 | 0.3941 |
| Other Current Liabilities, Total | 0 | 0.332 | |||
| Preferred Stock - Non Redeemable, Net | 96.398 | 0 | 0 | 0 | |
| Cash | 84.655 | 1.931 | 4.467 | 9.338 | |
| Other Current Assets, Total | 0.121 | 0.121 | 0.477 | ||
| Total Preferred Shares Outstanding | 0.03146 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 114.221 | 127.075 | 134.522 | 140.052 | 147.684 |
| Raha ja lühiajalised investeeringud | 112.816 | 125.508 | 131.777 | 139.52 | 146.92 |
| Raha ja ekvivalendid | 46.687 | 86.508 | 131.777 | 139.52 | 146.92 |
| Lühiajalised investeeringud | 66.129 | 39 | 0 | 0 | 0 |
| Prepaid Expenses | 1.121 | 1.446 | 2.624 | 0.411 | 0.643 |
| Other Current Assets, Total | 0.284 | 0.121 | 0.121 | 0.121 | 0.121 |
| Total Assets | 114.653 | 127.514 | 135.129 | 140.945 | 148.74 |
| Property/Plant/Equipment, Total - Net | 0.228 | 0.394 | 0.557 | 0.717 | 0.874 |
| Other Long Term Assets, Total | 0.204 | 0.045 | 0.05 | 0.176 | 0.182 |
| Total Current Liabilities | 4.967 | 5.203 | 4.7 | 3.988 | 4.406 |
| Accounts Payable | 0.931 | 1.557 | 0.574 | 0.619 | 1.809 |
| Accrued Expenses | 4.036 | 3.646 | 4.126 | 3.369 | 2.597 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 4.967 | 5.203 | 4.7 | 4.046 | 9.004 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 0 | 0 | 0.058 | 4.598 | |
| Total Equity | 109.686 | 122.311 | 130.429 | 136.899 | 139.736 |
| Preferred Stock - Non Redeemable, Net | 96.398 | 96.398 | 96.398 | 99.77 | 240.881 |
| Common Stock | 0.013 | 0.013 | 0.013 | 0.077 | 0.023 |
| Additional Paid-In Capital | 484.46 | 481.709 | 480.336 | 475.499 | 329.813 |
| Retained Earnings (Accumulated Deficit) | -471.132 | -455.809 | -446.318 | -438.447 | -430.981 |
| Total Liabilities & Shareholders’ Equity | 114.653 | 127.514 | 135.129 | 140.945 | 148.74 |
| Total Common Shares Outstanding | 13.017 | 13.017 | 13.0095 | 12.8248 | 3.90283 |
| Total Preferred Shares Outstanding | 0.03146 | 0.03146 | 0.03146 | 0.03255 | |
| Other Equity, Total | -0.053 | 0 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
| Raha majandustegevusest | -30.151 | -32.485 | -26.569 | -23.465 | -26.836 |
| Raha majandustegevusest | 0.026 | 0.119 | 0.304 | ||
| Mittelikviidsed varad | 168.066 | 1.448 | 1.568 | 1.524 | 2.158 |
| Makstud intressid | 0 | 0.079 | 0.327 | ||
| Muutused tööjõus | -3.305 | 3.367 | -1.87 | 0.762 | -1.934 |
| Tulu investeeringutelt | -12.555 | 6.3 | -4.082 | -21.905 | 14.883 |
| Kapitalikulutused | -0.021 | -0.033 | -0.012 | 0 | -0.057 |
| Muud rahavood investeeringutelt, kokku | -12.534 | 6.333 | -4.07 | -21.905 | 14.94 |
| Rahavood investeeringutelt | 104.284 | 40.86 | 25.62 | 44.295 | 4.726 |
| Aktsiate emiteerimine (tagasiost), neto | 104.284 | 40.86 | 25.62 | 47.143 | 8.059 |
| Laenu väljastamine (kustutamine), neto | 0 | -2.848 | -3.333 | ||
| Rahaline kogumuutus | 61.578 | 14.675 | -5.031 | -1.075 | -7.227 |
| Rahavoogudesse investeerimine | 0 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -15.323 | -194.912 | -185.421 | -177.55 | -170.084 |
| Cash From Operating Activities | -12.559 | -30.151 | -23.865 | -16.116 | -8.716 |
| Non-Cash Items | 2.672 | 168.066 | 166.702 | 165.302 | 165.037 |
| Changes in Working Capital | 0.092 | -3.305 | -5.146 | -3.868 | -3.669 |
| Cash From Investing Activities | -27.099 | -12.555 | 26.445 | 26.445 | 26.445 |
| Capital Expenditures | 0 | -0.021 | -0.021 | -0.021 | -0.021 |
| Other Investing Cash Flow Items, Total | -27.099 | -12.534 | 26.466 | 26.466 | 26.466 |
| Cash From Financing Activities | 0 | 104.284 | 104.267 | 104.261 | 104.261 |
| Issuance (Retirement) of Stock, Net | 0 | 104.284 | 104.267 | 104.261 | 104.261 |
| Net Change in Cash | -39.658 | 61.578 | 106.847 | 114.59 | 121.99 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| Fidelity Management & Research Company LLC | Investment Advisor | 12.1867 | 3351514 | 2974069 | 2022-12-31 | LOW |
| Perceptive Advisors LLC | Private Equity | 7.9613 | 2189462 | 908265 | 2022-12-31 | MED |
| Fairmount Funds Management LLC | Hedge Fund | 6.9138 | 1901397 | 989661 | 2022-12-31 | HIGH |
| Deep Track Capital LP | Hedge Fund | 6.6052 | 1816531 | 1816531 | 2022-12-31 | MED |
| Vivo Capital, LLC | Venture Capital | 6.1132 | 1681199 | 681199 | 2022-12-31 | MED |
| Cormorant Asset Management, LP | Hedge Fund | 5.9997 | 1650000 | 450000 | 2022-12-31 | MED |
| Altium Capital Management LP | Investment Advisor/Hedge Fund | 4.9284 | 1355372 | 910372 | 2022-12-31 | HIGH |
| Driehaus Capital Management, LLC | Investment Advisor/Hedge Fund | 4.8627 | 1337315 | 680954 | 2022-12-31 | MED |
| Logos Global Management LLC | Investment Advisor | 3.1452 | 864960 | 864960 | 2022-12-31 | HIGH |
| Ikarian Capital LLC | Hedge Fund | 2.4551 | 675176 | -24264 | 2022-12-31 | HIGH |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.3793 | 654326 | 123173 | 2022-12-31 | LOW |
| Rosalind Advisors, Inc. | Hedge Fund | 2.376 | 653438 | 653438 | 2021-12-31 | LOW |
| Tri Locum Partners LP | Hedge Fund | 2.3684 | 651330 | 19751 | 2022-12-31 | HIGH |
| Affinity Asset Advisors LLC | Hedge Fund | 1.718 | 472482 | 72439 | 2022-12-31 | HIGH |
| Sphera Funds Management Ltd. | Hedge Fund | 1.7066 | 469340 | 469340 | 2022-12-31 | HIGH |
| Ghost Tree Capital, LLC | Hedge Fund | 1.6363 | 450000 | -50000 | 2022-12-31 | HIGH |
| Violin (Jonathan) | Individual Investor | 0.9575 | 263321 | 0 | 2022-04-13 | LOW |
| Opaleye Management Inc. | Hedge Fund | 0.9516 | 261703 | 128203 | 2022-12-31 | MED |
| Medical Strategy GmbH | Investment Advisor | 0.9185 | 252605 | -18814 | 2022-09-30 | LOW |
| Point72 Asset Management, L.P. | Hedge Fund | 0.8181 | 225000 | 225000 | 2022-12-31 | HIGH |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
Astria Therapeutics, Inc. Company profile
Ettevõttest Astria Therapeutics, Inc.
Astria Therapeutics, Inc., endine Catabasis Pharmaceuticals, Inc. on biofarmatseutiline ettevõte. Ettevõte keskendub ravimeetodite väljatöötamisele patsientidele ja peredele, keda mõjutavad haruldased ja kitsad allergilised ja immunoloogilised haigused. Ettevõtte juhtiv programm STAR-0215 on prekliinilises arenduses päriliku angioödeemi (HAE) raviks. HAE on haruldane geneetiline haigus, mida iseloomustab raske, korduv, ettearvamatu, valulik ja mõnikord eluohtlik turse näos, jäsemetes, kõhus ja hingamisteedes. STAR-0215 on plasma kallikreiini monoklonaalne antikeha inhibiitor, mis on mõeldud HAE pikaajalise toimega rünnaku ennetamiseks.
| Industry: | Bio Therapeutic Drugs |
75 State Street
Suite 1400
BOSTON
MASSACHUSETTS 02109
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com